Cargando…

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening

The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testi...

Descripción completa

Detalles Bibliográficos
Autores principales: Larremore, Daniel B., Wilder, Bryan, Lester, Evan, Shehata, Soraya, Burke, James M., Hay, James A., Tambe, Milind, Mina, Michael J., Parker, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775777/
https://www.ncbi.nlm.nih.gov/pubmed/33219112
http://dx.doi.org/10.1126/sciadv.abd5393
_version_ 1783630542275608576
author Larremore, Daniel B.
Wilder, Bryan
Lester, Evan
Shehata, Soraya
Burke, James M.
Hay, James A.
Tambe, Milind
Mina, Michael J.
Parker, Roy
author_facet Larremore, Daniel B.
Wilder, Bryan
Lester, Evan
Shehata, Soraya
Burke, James M.
Hay, James A.
Tambe, Milind
Mina, Michael J.
Parker, Roy
author_sort Larremore, Daniel B.
collection PubMed
description The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are too low to detect, followed by exponential viral growth, leading to peak viral load and infectiousness and ending with declining titers and clearance. Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity. We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.
format Online
Article
Text
id pubmed-7775777
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-77757772021-01-14 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening Larremore, Daniel B. Wilder, Bryan Lester, Evan Shehata, Soraya Burke, James M. Hay, James A. Tambe, Milind Mina, Michael J. Parker, Roy Sci Adv Research Articles The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and the control of virus spread will be facilitated by robust population screening, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are too low to detect, followed by exponential viral growth, leading to peak viral load and infectiousness and ending with declining titers and clearance. Given the pattern of viral load kinetics, we model the effectiveness of repeated population screening considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective screening depends largely on frequency of testing and speed of reporting and is only marginally improved by high test sensitivity. We therefore conclude that screening should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary. American Association for the Advancement of Science 2021-01-01 /pmc/articles/PMC7775777/ /pubmed/33219112 http://dx.doi.org/10.1126/sciadv.abd5393 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Larremore, Daniel B.
Wilder, Bryan
Lester, Evan
Shehata, Soraya
Burke, James M.
Hay, James A.
Tambe, Milind
Mina, Michael J.
Parker, Roy
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title_full Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title_fullStr Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title_full_unstemmed Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title_short Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
title_sort test sensitivity is secondary to frequency and turnaround time for covid-19 screening
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775777/
https://www.ncbi.nlm.nih.gov/pubmed/33219112
http://dx.doi.org/10.1126/sciadv.abd5393
work_keys_str_mv AT larremoredanielb testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT wilderbryan testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT lesterevan testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT shehatasoraya testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT burkejamesm testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT hayjamesa testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT tambemilind testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT minamichaelj testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening
AT parkerroy testsensitivityissecondarytofrequencyandturnaroundtimeforcovid19screening